AG
ASMB icon

Algert Global’s Assembly Biosciences ASMB Stock Holding History

Algert Global’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,491
Closed -$69K – 1131
2022
Q3 		$69K Hold
3,491
– – ﹤0.01% 1127
2022
Q2 		$88K Buy
3,491
+407
+13% +$9.37K 0.01% 1129
2022
Q1 		$76K Buy
+3,084
New +$66.2K 0.01% 1121
2020
Q2 		– Sell
-959
Closed -$171K – 417
2020
Q1 		$171K Buy
+959
New +$206K 0.07% 318
2019
Q4 		– Sell
-1,346
Closed -$159K – 378
2019
Q3 		$159K Buy
1,346
+220
+20% +$33.3K 0.06% 296
2019
Q2 		$182K Buy
+1,126
New +$214K 0.07% 285

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Algert Global's ASMB Position: Q4 2022 in Review

Algert Global sold out of Assembly Biosciences (ASMB) in Q4 2022, closing a stake of 3,491 shares — an estimated $69K sold.

Algert Global first reported a position in ASMB in Q2 2019 and held it in 6 quarters. The position peaked at $182K in Q2 2019. 39 funds tracked by Wall St. Rank hold ASMB as of Q4 2022.

  • Algert Global reported no remaining Assembly Biosciences position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 3,491 Assembly Biosciences shares in Q4 2022, an estimated $69K.
  • Algert Global first reported a position in Assembly Biosciences in Q2 2019 and held it in 6 quarters.
  • Algert Global's Assembly Biosciences position peaked at $182K in Q2 2019.
  • 39 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.